Splenomegaly during oxaliplatin-based chemotherapy for colorectal carcinoma

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3357-3362

  Jung, Eun Joo ^a   Chun Geun, Ryu ^a   Kim, Gangmi ^a   Kim, Su Ran ^a   Park, Hee Sun ^b   Kim, Young Jun ^b   Hwang, Dae Yong ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Colorectal cancer; Oxaliplatin; Splenomegaly; Thrombocytopenia

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; ORGAN SIZE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SPLENOMEGALY;

EID: 84865680528     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Curtis BR, Kaliszewski J, Marques MB, Saif MW, Nabelle L, Blank J, McFarland JG and Aster RH: Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 81: 193-198, 2006.
2. Culy CR, Clemett D and Wiseman LR. Oxaliplatin: A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs 60: 895-924, 2000.
3. Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA and Kopetz S: Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28: 2549-2555, 2010.
4. Goldberg R, Sargent DJ and Morton RF: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic olorectal cancer. J Clin Oncol 22: 23-30, 2004.
5. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G and Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466, 2004.
6. Angitapalli R, Litwin AM, Kumar PR, Nasser E, Lombardo J, Mashtare T, Wilding GE and Fakih MG: Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer. Oncology 76: 363-368, 2009.
7. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A and Gourtsoyiannis N: Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 7: 246-248, 1997.
8. Harris A, Kamishima T, Hao HY, Kato F, Omatsu T, Onodera Y, Terae S and Shirato H: Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol 75: e97-101, 2010.
9. Cleary JM, Tanabe KT, Lauwers GY and Zhu AX: Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. Oncologist 14: 1095-1105, 2009.
10. Slade JH, Alattar ML, Fogelman DR, Overman MJ, Agarwal A, Maru DM, Coulson RL, Charnsangavej C, Vauthey JN, Wolff RA and Kopetz S: Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8: 225-230, 2009.
11. Schouten van der Velden AP, Punt CJ, Van Krieken JH, Derleyn VA and Ruers TJ: Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month. Euro J Surg Oncol 34: 353-355, 2008.
12. Tisman G, MacDonald D, Shindell N, Reece E, Patel P, Honda N, Nishimora EK, Garris J, Shannahan W, Chisti N, McCarthy J, Nasser Moaddeli S, Sargent D and Plant A: Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 22: 3202-3204, 2004.
13. Chabner BA and Longo DL: Cancer Chemotherapy and Biotherapy: Principles and Practice, 5th ed. Lippincott Williams & Wilkins. Philadelpia, USA pp. 370-370, 2011.
14. Soubrane O, Brouquet A, Zalinski S, Terris B, Brézault C, Mallet V, Goldwasser F and Scatton O: Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 251: 454-460, 2010.
15. Nathan DG, Orkin SH, Ginsburg D and Look AT: Clinical and laboratory approach to the patient with bleeding. In: Nathan and Oski's Hematology of Infancy and Childhood, 6th ed. Elsevier. Philadelpia, U.S.A. p. 1515, 2003.